Differential effects of immunologic challenge on self-stimulation from the nucleus accumbens and the substantia nigra

Pharmacology Biochemistry and Behavior

Volumn 58, Issue 4, 1997, Pages 881-886

  Zacharko, Robert M ^a   Zalcman, Steve ^a   MacNeil, Glenda ^a   Andrews, Monique ^a   Mendella, Paul D ^a   Anisman, Hymie ^a  

^a CARLETON UNIVERSITY   (Canada)

Author keywords

Brain stimulation; Mouse; Nucleus accumbens; Sheep red blood cells; Substantia nigra

Indexed keywords

DOPAMINE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN DEPTH STIMULATION; CONTROLLED STUDY; IMMUNE RESPONSE; LOCOMOTION; MALE; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; SELF STIMULATION; SHEEP ERYTHROCYTE; STRESS; SUBSTANTIA NIGRA;

ANIMALS; ANTIGENS; ELECTRODES, IMPLANTED; ERYTHROCYTES; MALE; MICE; NUCLEUS ACCUMBENS; SELF STIMULATION; SHEEP; SUBSTANTIA NIGRA;

EID: 0031406440     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(97)00053-1     Document Type: Article

References (39)

1. Anisman H., Zalcman S., Zacharko R. M. The impact of stressors on immune and central neurotransmitter activity. Bidirectional communication Rev. Neurosci. 4:1993;1-34.
2. Anisman H., Zalcman S., Shanks N., Zacharko R. M. Multisystem regulation of performance deficits induced by stressors. An animal model of depression Boulton A., Baker G., Martin-Iverson M. Neuromethods. Animal models of psychiatry:1991;1-59 Humana Press, Clifton, NJ.
3. Besedovsky H. O., Del Rey A. Physiological implications of the immune-neuro-endocrine network. Ader R., Felten D. L., Cohen N. Psychoneuroimmunology. 1991;589-608 Academic Press, San Diego.
4. Besedovsky H., Del Rey A., Sorkin E., Da Prada M., Burri R., Honegger C. The immune response evokes changes in noradrenergic neurons. Science. 221:1983;564-566.
5. Besedovsky H. O., Sorkin E., Felix D., Haas H. Hypothalamic changes during the immune response. Eur. J. Immunol. 7:1977;323-325.
6. Blalock J. E. Production of peptide hormones and neurotransmitters by the immune system. Ishizaka K., Lachmann P. J. Chemical immunology. 1992;1-24 Karger, Basel.
7. Blalock J. E. The immune system as a sensory organ. J. Immunol. 132:1984;1067-1070.
8. Bluthe R. M., Dantzer R., Kelley K. W. CRF is not involved in the behavioural efffects of peripherally injected interleukin-1 in the rat. Neurosci. Res. Commun. 5:1989;149-154.
9. Carlson S. L., Felten D. L., Livnat S., Felten S. Y. Alterations of monoamines in specific central autonomic nuclei following immunization in mice. Brain Behav. Immunity. 1:1987;52-63.
10. Deutch A. Y., Roth R. H. The determinants of stress-induced activation of the prefrontal cortical dopamine system. Uylings H. B. M., Van Eden C. G., De Bruin J. P. C., Corner M. A., Feenstra M. G. F. Progress in brain research. 1990;367-403 Elsevier, New York.
11. Dunn A. J. Interleukin-1 as a stimulator of hormone secretion. Prog. Neuro. Endocrinol. Immunol. 3:1990;26-34.
12. Dunn A. J. Changes in plasma and brain tryptophan and brain serotonin and 5-hydroxyindoleacetic acid after foot shock stress. Life Sci. 42:1988;1847-1853.
13. Dunn A. J., Welch J. Stress- and endotoxin-induced increases in brain tryptophan and serotonin metabolism depend on sympathetic nervous system activity. J. Neurochem. 57:1991;1615-1622.
14. Dunn A. J., Antoon M., Chapman Y. Reduction of exploratory behavior by intraperitoneal injection of interleukin-1 involves brain corticotropin-releasing factor. Brain. Res. Bull. 26:1991;539-542.
15. Dunn A. J., Powell M. L., Meitin C., Small P. A. Virus infection as a stressor. Influenza virus elevates plasma concentrations of corticosterone, and brain concentrations of MHPG and tryptophan Physiol. Behav. 45:1989;591-594.
16. Felten D. L., Cohen N., Ader R., Felten S. Y., Carlson S. L., Roszman T. L. Central neural circuits involved in neural-immune interactions. Ader R., Felten D. L., Cohen N. Psychoneuroimmunology. 1991;3-25 Academic Press, San Diego.
17. Hellerstein M. K., Meydani S. I., Meydani M., Wu K., Dinarello C. A. Interleukin-1-induced anorexia in the rat. Influence of prostaglandins. J. Clin. Invest. 84:1989;228-235.
18. Kabiersch A., Del Rey A., Honegger C. G., Besedovsky H. O. Interleukin-1 induces changes in norepinephrine metabolism in the rat brain. Brain Behav. Immun. 2:1988;267-274.
19. Kent S., Bluthe R. M., Kelley K. W., Dantzer R. Sickness behavior as a new target for drug development. Trends Pharmacol. Sci. 13:1992;24-28.
20. LeMoal M., Simon H. Mesocorticolimbic dopaminergic network. Functional and regulatory roles Physiol. Rev. 71:1991;155-234.
21. 5-enkephalinamide induces rapid recovery of responding for electrical brain stimulation from the ventral tegmental area following uncontrollable footshock. Brain Res. Bull. 28:1991;337-341.
22. Maes M., Smith R., Scharpe S. The monocyte-T-lymphocyte hypothesis of major depression. Psychoneuroendocrinology. 20:1995;111-116.
23. Maier S. F., Watkins L. R. Intracerebroventricular interleukin-1 receptor anatgonist blocks the enhancement of fear conditioning and interference with escape produced by inescapable shock. Brain Res. 695:1995;279-282.
24. McCarthy D. O., Kluger M. J., Vander A. J. The role of interleukin-1 in the suppression of food intake during infection. Am. J. Clin. Nutr. 42:1985;1179-1182.
25. McEwen B., Brinton R., Chao H., Coirini H., Gannon M., Gould E. The hippocampus. A site for modulatory interaction between steroid hormones, neurotransmitters and neuropeptides Muller E. R., MacLoed R. Neuroendocrine perspectives. 1990;93-131 Springer, New York.
26. Mefford I. N., Heyes M. P. Increased biogenic amine release in mouse hypothalamus following immunological challenge. Antagonism by indomethacin J. Neuroimmunol. 27:1990;55-61.
27. Otterness I. G., Seymour P. A., Golden H. W., Reynolds J. A., Daumy G. O. The effects of continuous administration of murine interleukin-1a in the rat. Physiol. Behav. 43:1988;797-804.
28. Plata-Salaman C. R. Immunomodulators and feeding regulation. A humoral link between the immune and nervous systems Brain. Behav. Immun. 3:1989;193-213.
29. Saphier D., Abramsky O., Mor G., Ovadia H. Multiunit electrical activity in conscious rats during an immune response. Brain Behav. Immun. 1:1987;40-51.
30. Spadaro F., Dunn A. J. Intracerebroventricular administration of interleukin-1 to mice alters investigation of stimuli in a novel environment. Brain Behav. Immun. 4:1990;308-322.
31. Wolfe C., Zacharko R. M. Desmethylimipramine promotes recovery of self-stimulation from the prefrontal cortex following footshock. Brain Res. Bull. 27:1991;601-604.
32. Yirmiya R. Endotoxin produces a depressive-like episode in rats. Brain Res. 711:1996;163-174.
33. Zacharko R. M., Anisman H. Stressor-induced anhedonia in the mesocorticolimbic system. Neurosci. Biobehav. Rev. 15:1991;1-15.
34. Zacharko R. M., Bowers W. J., Kelley M. S., Anisman H. Prevention of stressor-induced disturbances of self-stimulation by desmethylimipramine. Brain Res. 321:1984;175-179.
35. Zacharko R. M., Bowers W. J., Kokkinidis L., Anisman H. Region-specific reductions of intracranial self-stimulation after uncontrollable stress. Possible effects on reward processes Behav. Brain Res. 9:1983;129-141.
36. Zacharko R. M., Kasian M., Irwin J., Zalcman S., Lalonde G., MacNeil G., Anisman H. Behavioral characterization of intracranial self-stimulation from mesolimbic, mesocortical, nigrostriatal, hypothalamic and extra-hypothalamic sites in the non-inbred CD-1 mouse strain. Behav. Brain Res. 36:1990;251-281.
37. Zalcman S., Green-Johnson J., Murray L., Dyck D., Anisman H., Greenberg A. Hypothalamic and hippocampal amine alterations after peripheral interleukin-1, -2 or -6 administration in mice. Soc. Neurosci. Abstr. 18:1992;1013.
38. Zalcman S., Shanks N., Anisman H. Time-dependent variations of central norepinephrine and dopamine following antigen administration. Brain Res. 557:1991;69-76.
39. Zalcman S., Shanks N., Merali Z., Anisman H. Alterations of central catecholamines associated with primary and secondary immunological challenge. Soc. Neurosci. Abstr. 17:1991;1202.